Search

Author/Creator Howes, A.

1. IBRUTINIB + CHEMOIMMUNOTHERAPY (CIT) FOR RELAPSED/REFRACTORY MATURE B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL) IN CHILDREN (SPARKLE TRIAL): INITIAL SAFETY, PK, AND EFFICACY. (12th June 2019)

Authors:
Burke, A.; Beishuizen, A.; Bhojwani, D.; Burkhardt, B.; Minard‐Colin, V.; Norris, R.; Kabickova, E.; Pinarli, F.; Tacyildiz, N.; de Jong, J.; Liu, G.; Howes, A.; Nottage, K.; Salman, M.; Woot de Trixhe, X.; Cairo, M.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
57
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. S209: PRIMARY RESULTS FROM THE PHASE 3 SHINE STUDY OF IBRUTINIB IN COMBINATION WITH BENDAMUSTINE-RITUXIMAB (BR) AND R MAINTENANCE AS A FIRST-LINE TREATMENT FOR OLDER PATIENTS WITH MANTLE-CELL LYMPHOMA. (23rd June 2022)

Authors:
Wang, M. L.; Jurczak, W.; Jerkeman, M.; Trotman, J.; Zinani, P. L.; Belada, D.; Boccomini, C.; Flinn, I. W.; Giri, P.; Goy, A.; Hamlin, P. A.; Hermine, O.; Hernández-Rivas, J.-Á.; Hong, X.; Kim, S. J.; Lewis, D.; Mishima, Y.; Özcan, M.; Perini, G. F.; Pocock, C.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
110
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. INTEGRATED ANALYSIS: OUTCOMES OF IBRUTINIB‐TREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LEUKEMIA (CLL/SLL) WITH HIGH‐RISK PROGNOSTIC FACTORS. (June 2017)

Authors:
Kipps, T.J.; Fraser, G.; Coutre, S.E.; Brown, J.R.; Barrientos, J.C.; Barr, P.M.; Byrd, J.C.; O'Brien, S.M.; Dilhuydy, M.; Hillmen, P.; Jaeger, U.; Moreno, C.; Cramer, P.; Stilgenbauer, S.; Chanan‐Khan, A.A.; Mahler, M.; Salman, M.; Cheng, M.; Londhe, A.; Ninomoto, J.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
109
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. IBRUTINIB INCREASES THE SYSTEMIC EXPOSURE OF RITUXIMAB: PHARMACOKINETIC RESULTS FROM THE HELIOS TRIAL. (June 2017)

Authors:
Cramer, P.; Demirkan, F.; Fraser, G.; Pristupa, A.; Bartlett, N.; Dilhuydy, M.; Loscertales, J.; Avigdor, A.; Rule, S.; Samoilova, O.; Goy, A.; Ganguly, S.; Poggesi, I.; Lavezzi, S.M.; De Nicolao, G.; de Jong, J.; Neyens, M.; Salman, M.; Howes, A.; Mahler, M.
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Page Start:
232
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗